ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

CPRU Program Gets Basic Concept Approval

October 2, 1987

Schmidt Says He Erred In Remarks About Pauling’s Grant Applications

March 23, 1979

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

September 10, 1976

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008